Krystal Biotech, Inc. (KRYS) by event type
KRYS moves most on analyst upgrades — a median of +0.69% at 30 minutes across 11 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the KRYS overview →
How KRYS reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 237 of 2,717 | 11 | +0.69% | 73% | -0.33% |
| Coverage initiations 1,079 of 2,283 | 21 | +0.01% | 57% | -0.47% |
| Rating reiterations 1,583 of 3,522 | 105 | 0.00% | 50% | -0.21% |
| Price-target raises 52 of 1,790 | 19 | +0.47% | 58% | +0.53% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how KRYS usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · KRYS overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | 251 | -0.05% | 50% |
| DOVA PHARMACEUTICALS (DOVA) | 251 | -0.10% | 46% |
| Mersana Therapeutics, Inc. (MRSN) | 251 | -0.20% | 46% |
| Soligenix, Inc. (SNGX) | 251 | -0.71% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.